INSY
Insys Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Insys Therapeutics Inc develops and commercializes drugs delivery systems targeting the oncology space. The company manufactures cannabinoid formulation, and sublingual spray drug delivery technology for the US and Europe markets.
Market Cap: 741 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.insysrx.com
Shares Outstanding: 73.3 Million
Float: 72.7 Million
Dividend: 0.0 (0.0%)
Beta: 0.832651
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 985 trading days
From: 2015-07-31 To: 2019-06-07
Lowest Point:
Stoke Therapeutics Files Proposed Terms For IPO
via: SeekingAlpha at 2019-06-11 08:24:08:000
Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe genetic diseases with a focus on dominant loss-of-function [haploinsufficient] diseases of … read more...
Stoke Therapeutics Files Proposed Terms For IPO
via: SeekingAlpha at 2019-06-11 08:24:08:000
Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe genetic diseases with a focus on dominant loss-of-function [haploinsufficient] diseases of … read more...
Stoke Therapeutics Files Proposed Terms For IPO
via: SeekingAlpha at 2019-06-11 08:24:08:000
Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe genetic diseases with a focus on dominant loss-of-function [haploinsufficient] diseases of … read more...
Microcaps dominate midday movers
via: SeekingAlpha at 2019-06-10 08:51:13:000
Gainers: Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) … read more...
Healthcare stocks among premarket losers
via: SeekingAlpha at 2019-06-10 05:11:39:000
INSYS Therapeutics (NASDAQ: INSY ) -63% onfiling Chapter 11 for bankruptcy. More news on: INSYS Therapeutics, Inc., Spark Therapeutics, Inc., Genocea Biosciences, Inc., Stocks on the move, Read more … read more...
It's over. Insys to sell assets under bankruptcy filing; shares off 58% premarket
via: SeekingAlpha at 2019-06-10 03:13:09:000
Buckling under the weight of opioid lawsuits, INSYS Therapeutics (NASDAQ: INSY ) has filed for Chapter 11 bankruptcy and will sell substantially all of its assets. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2015-06-08 | 2015-05-26 | 2015-06-05 00:00:00 -0400 | 0.5 | 2.0 | 1.0 |